SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Dec-23 4:48 PM View: | Nephros Inc. (NEPH) | 13-Dec-23 | Grant | 9,291 | -- | -- | 24% 39.34K to 48.63K | |
14-Aug-23 5:35 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 10-Aug-23 | Payment of Exercise | 12,000 | $0.49 | $5,880.00 | (10%) 124.56K to 112.56K | |
11-Jul-23 9:15 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 05-Jul-23 | Grant | 40,000 | -- | -- | 47% 84.56K to 124.56K | |
09-Jan-23 4:33 PM View: | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 27,613 | -- | -- | 236% 11.72K to 39.34K | |
12-Aug-22 4:07 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 10-Aug-22 | Grant | 75,000 | -- | -- | 785% 9.56K to 84.56K | |
16-Dec-21 9:17 PM View: | Nephros Inc. (NEPH) | 14-Dec-21 | Grant | 4,582 | -- | -- | 64% 7.14K to 11.72K | |
08-Jan-21 5:31 PM View: | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,666 | -- | -- | 105% 3.48K to 7.14K | |
18-Dec-19 5:13 PM View: | Nephros Inc. (NEPH) | 16-Dec-19 | Grant | 3,227 | -- | -- | 1291% 0.25K to 3.48K | |
13-Sep-19 4:32 PM View: | Nephros Inc. (NEPH) | 11-Sep-19 | Market Purchase | 250 | $6.45 | $1,612.50 | 100% 0 to 0.25K | 1% |